当前位置:首页 - 行情中心 - 国邦医药(605507) - 财务分析

国邦医药

(605507)

  

流通市值:70.36亿  总市值:130.32亿
流通股本:3.02亿   总股本:5.59亿

国邦医药(605507)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润4.54亿元,每股收益0.82元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益806138.14万元,未分配利润378885.37万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产1080809.26万元,负债274671.12万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入3,026,283,783.221,440,055,937.135,890,839,205.644,418,147,150.19
营业总成本2,520,305,808.061,209,046,358.945,007,120,720.063,724,615,529.84
其他经营收益
营业利润522,095,865.12248,478,156.59895,067,447.8673,947,665.53
利润总额521,309,059.35248,828,597.45887,969,784.1664,632,411.33
净利润453,993,510.87214,259,675.01780,577,499.03578,638,198.06
每股收益
其他综合收益----
综合收益总额453,993,510.87214,259,675.01780,577,499.03578,638,198.06
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计5,987,061,299.826,261,211,433.945,874,299,808.135,659,848,826.36
非流动资产:
非流动资产合计4,821,031,333.44,853,472,522.64,906,136,359.454,973,538,184.63
资产总计10,808,092,633.2211,114,683,956.5410,780,436,167.5810,633,387,010.99
流动负债:
流动负债合计2,208,722,440.652,492,043,797.772,557,787,418.172,562,823,970.69
非流动负债:
非流动负债合计537,988,742.88363,364,008.22170,591,500.78224,703,960.42
负债合计2,746,711,183.532,855,407,805.992,728,378,918.952,787,527,931.11
所有者权益(或股东权益):
归属于母公司股东权益合计8,056,976,824.518,255,276,580.428,047,340,282.197,840,370,923.66
股东权益合计8,061,381,449.698,259,276,150.558,052,057,248.637,845,859,079.88
负债和股东权益合计10,808,092,633.2211,114,683,956.5410,780,436,167.5810,633,387,010.99
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计2,493,814,104.671,083,518,233.354,574,322,268.543,400,423,392.91
经营活动现金流出小计2,390,937,218.071,435,189,997.873,867,911,412.693,367,545,491.3
经营活动产生的现金流量净额102,876,886.6-351,671,764.52706,410,855.8532,877,901.61
投资活动产生的现金流量:
投资活动现金流入小计7,889,926,988.635,232,113,917.555,323,802,456.311,332,474,826.26
投资活动现金流出小计8,117,023,257.095,394,088,271.95,837,648,418.781,733,737,826.04
投资活动产生的现金流量净额-227,096,268.46-161,974,354.35-513,845,962.47-401,262,999.78
筹资活动产生的现金流量:
筹资活动现金流入小计846,045,385.23560,269,185.23690,903,824.79770,140,750.55
筹资活动现金流出小计1,088,149,639.28293,764,345.331,077,397,819.21921,177,462.39
筹资活动产生的现金流量净额-242,104,254.05266,504,839.9-386,493,994.42-151,036,711.84
汇率变动对现金及现金等价物的影响4,476,304.155,105,660.3927,075,876.7114,130,878.73
现金及现金等价物净增加额-361,847,331.76-242,035,618.58-166,853,224.33-505,290,931.28
期末现金及现金等价物余额1,172,524,232.081,292,335,945.261,534,371,563.841,195,933,856.89
补充资料:
现金及现金等价物的净增加额-361,847,331.76--166,853,224.33-
最新报告期:2025-08-13
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华西证券崔文亮,徐顺利1.712.062.402025-08-13
中信证券陈竹,王凯旋,韩世通1.732.022.352025-08-01
开源证券阮帅,余汝意1.782.212.492025-07-31
西部证券李梦园1.631.912.212025-07-31
招商证券侯彪,梁广楷,许菲菲1.802.312.782025-07-30
TOP↑